The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation

Objective Proper interactions between the intestinal mucosa, gut microbiota and nutrient flow are required to establish homoeostasis of the host. Since the proximal part of the small intestine is the first region where these interactions occur, and since most of the nutrient absorption occurs in the jejunum, it is important to understand the dynamics of metabolic responses of the mucosa in this intestinal region. Design Germ-free mice aged 8–10 weeks were conventionalised with faecal microbiota, and responses of the jejunal mucosa to bacterial colonisation were followed over a 30-day time course. Combined transcriptome, histology, 1H NMR metabonomics and microbiota phylogenetic profiling analyses were used. Results The jejunal mucosa showed a two-phase response to the colonising microbiota. The acute-phase response, which had already started 1 day after conventionalisation, involved repression of the cell cycle and parts of the basal metabolism. The secondary-phase response, which was consolidated during conventionalisation (days 4–30), was characterised by a metabolic shift from an oxidative energy supply to anabolic metabolism, as inferred from the tissue transcriptome and metabonome changes. Detailed transcriptome analysis identified tissue transcriptional signatures for the dynamic control of the metabolic reorientation in the jejunum. The molecular components identified in the response signatures have known roles in human metabolic disorders, including insulin sensitivity and type 2 diabetes mellitus. Conclusion This study elucidates the dynamic jejunal response to the microbiota and supports a prominent role for the jejunum in metabolic control, including glucose and energy homoeostasis. The molecular signatures of this process may help to find risk markers in the declining insulin sensitivity seen in human type 2 diabetes mellitus, for instance.

[1]  J. Doré,et al.  Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice , 2012, Mucosal Immunology.

[2]  M. Santo,et al.  Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. , 2012, Diabetes technology & therapeutics.

[3]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[4]  V. Tremaroli,et al.  Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88 , 2011, Gut.

[5]  P. François,et al.  Altered Gut Microbiota and Endocannabinoid System Tone in Obese and Diabetic Leptin-Resistant Mice: Impact on Apelin Regulation in Adipose Tissue , 2011, Front. Microbio..

[6]  Arthur Kaser,et al.  Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.

[7]  M. Nieto,et al.  An epigenetic mark that protects the epithelial phenotype in health and disease. , 2011, Cell stem cell.

[8]  D. Haro,et al.  Human HMGCS2 Regulates Mitochondrial Fatty Acid Oxidation and FGF21 Expression in HepG2 Cell Line* , 2011, The Journal of Biological Chemistry.

[9]  C. Elson,et al.  Experimental inflammatory bowel disease: insights into the host-microbiota dialog. , 2011, Immunity.

[10]  E. Want,et al.  Colonization-Induced Host-Gut Microbial Metabolic Interaction , 2011, mBio.

[11]  H. Kita,et al.  The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses , 2011, The Journal of Immunology.

[12]  D. Haro,et al.  Human HMGCS 2 regulates mitochondrial fatty acid oxidation and FGF 21 expression in HepG 2 cell line . , 2011 .

[13]  A. Mackensen,et al.  Suppression of T-cell responses by tumor metabolites , 2011, Cancer Immunology, Immunotherapy.

[14]  Qian Wang,et al.  Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity. , 2010, Blood.

[15]  F. Bäckhed,et al.  Coordinated regulation of the metabolome and lipidome at the host-microbial interface. , 2010, Biochimica et biophysica acta.

[16]  F. Rubino,et al.  Diabetes Surgery: A New Approach to an Old Disease , 2009, Diabetes Care.

[17]  W. D. de Vos,et al.  Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults , 2009, Environmental microbiology.

[18]  Elaine Holmes,et al.  Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes , 2008, Molecular systems biology.

[19]  B. Viollet,et al.  Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. , 2008, Cell metabolism.

[20]  K. Rock,et al.  How dying cells alert the immune system to danger , 2008, Nature Reviews Immunology.

[21]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[22]  M. Curet,et al.  Gastric bypass reduces biochemical cardiac risk factors. , 2005, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[23]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[24]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[25]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[26]  F. Rubino Bariatric surgery: effects on glucose homeostasis , 2006, Current opinion in clinical nutrition and metabolic care.

[27]  F. Shanahan,et al.  The gut flora as a forgotten organ , 2006, EMBO reports.

[28]  W. Liang,et al.  TM4 microarray software suite. , 2006, Methods in enzymology.

[29]  W. Liang,et al.  9) TM4 Microarray Software Suite , 2006 .

[30]  Ziv Bar-Joseph,et al.  STEM: a tool for the analysis of short time series gene expression data , 2006, BMC Bioinformatics.

[31]  Mitsuo Sakamoto,et al.  Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. , 2005, Journal of medical microbiology.

[32]  D. Melton,et al.  Direct regulation of intestinal fate by Notch. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[34]  D. Gauguier,et al.  Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. , 2005, Analytical chemistry.

[35]  M. Bessler,et al.  Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.

[36]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Forman,et al.  Variable regulation of glutamate cysteine ligase subunit proteins affects glutathione biosynthesis in response to oxidative stress. , 2004, Archives of biochemistry and biophysics.

[38]  C. Neut,et al.  Self inflicted rectal ulcer: hearing is believing , 2003, Gut.

[39]  W. Dröge,et al.  Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma , 2004, Journal of Cancer Research and Clinical Oncology.

[40]  Johan Trygg,et al.  O2‐PLS, a two‐block (X–Y) latent variable regression (LVR) method with an integral OSC filter , 2003 .

[41]  J. Nicholson,et al.  NMR and pattern recognition studies on liver extracts and intact livers from rats treated with alpha-naphthylisothiocyanate. , 2002, Biochemical pharmacology.

[42]  P. Vaupel,et al.  Pyruvate kinase type M2: a crossroad in the tumor metabolome , 2002, British Journal of Nutrition.

[43]  P. Calder,et al.  Fatty acids and lymphocyte functions , 2002, British Journal of Nutrition.

[44]  J. Gordon,et al.  How host-microbial interactions shape the nutrient environment of the mammalian intestine. , 2002, Annual review of nutrition.

[45]  J. Brosnan Glutamate, at the interface between amino acid and carbohydrate metabolism. , 2000, The Journal of nutrition.

[46]  Guoyao Wu,et al.  Intestinal mucosal amino acid catabolism. , 1998, The Journal of nutrition.

[47]  D F Horrobin,et al.  Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications. , 1998, Critical reviews in oncology/hematology.

[48]  G. Weber,et al.  Enzymic imbalance in serine metabolism in rat hepatomas. , 1986, The Biochemical journal.

[49]  J. McBride Ribavirin and RSV: A new approach to an old disease , 1985, Pediatric pulmonology.

[50]  H. G. Windmueller,et al.  Uptake and metabolism of plasma glutamine by the small intestine. , 1974, The Journal of biological chemistry.

[51]  M. Dempsey Regulation of steroid biosynthesis. , 1974, Annual review of biochemistry.

[52]  S. Spicer DIAMINE METHODS FOR DIFFERENTIATING MUCOSUBSTANCES HISTOCHEMICALLY , 1965 .